This page lists the SEC filings reported by VIKING GLOBAL INVESTORS LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2019-07-12 | VIKING GLOBAL INVESTORS LP | Urovant Sciences Ltd. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2019-07-12 | VIKING GLOBAL INVESTORS LP | Axovant Gene Therapies Ltd. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2019-07-12 | VIKING GLOBAL INVESTORS LP | Arbutus Biopharma Corp | 0 | 0.0% | EDGAR |
| SC 13D/A | 2019-07-12 | VIKING GLOBAL INVESTORS LP | Myovant Sciences Ltd. | 0 | 0.0% | EDGAR |
| SC 13D | 2019-07-08 | VIKING GLOBAL INVESTORS LP | BridgeBio Pharma, Inc. | 26,620,991 | 22.1% | EDGAR |
| SC 13D | 2019-06-14 | VIKING GLOBAL INVESTORS LP | Myovant Sciences Ltd. | 40,765,599 | 45.6% | EDGAR |
| SC 13D/A | 2019-03-19 | VIKING GLOBAL INVESTORS LP | Axovant Sciences Ltd. | 105,952,381 | 58.2% | EDGAR |
| SC 13G/A | 2019-02-19 | VIKING GLOBAL INVESTORS LP | BERRY GLOBAL GROUP INC | 6,945,161 | 5.3% | EDGAR |
| SC 13G/A | 2019-01-11 | VIKING GLOBAL INVESTORS LP | Parsley Energy, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2019-01-11 | VIKING GLOBAL INVESTORS LP | Jianpu Technology Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2019-01-11 | VIKING GLOBAL INVESTORS LP | UNITED STATES STEEL CORP | 0 | 0.0% | EDGAR |
| SC 13G/A | 2019-01-11 | VIKING GLOBAL INVESTORS LP | Deciphera Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2019-01-10 | VIKING GLOBAL INVESTORS LP | ABEONA THERAPEUTICS INC. | 293,518 | 0.6% | EDGAR |
| SC 13G/A | 2019-01-10 | VIKING GLOBAL INVESTORS LP | ENCANA CORP | 8,992,541 | 0.9% | EDGAR |
| SC 13G/A | 2019-01-10 | VIKING GLOBAL INVESTORS LP | MIDDLEBY CORP | 620,141 | 1.1% | EDGAR |
| SC 13G/A | 2019-01-10 | VIKING GLOBAL INVESTORS LP | Moderna, Inc. | 17,081,164 | 5.2% | EDGAR |
| SC 13G/A | 2019-01-10 | VIKING GLOBAL INVESTORS LP | Eidos Therapeutics, Inc. | 1,986,201 | 5.4% | EDGAR |
| SC 13G/A | 2019-01-10 | VIKING GLOBAL INVESTORS LP | Myovant Sciences Ltd. | 38,341,357 | 56.0% | EDGAR |
| SC 13G/A | 2019-01-10 | VIKING GLOBAL INVESTORS LP | aTYR PHARMA INC | 3,006,300 | 9.5% | EDGAR |
| SC 13G/A | 2019-01-10 | VIKING GLOBAL INVESTORS LP | BERRY GLOBAL GROUP INC | 5,517,250 | 4.2% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.